PDE-5 inhibition impedes TSP-1 expression, TGF-beta activation and matrix accumulation in experimental glomerulonephritis.

PDE-5 inhibition impedes TSP-1 expression, TGF-beta activation and matrix accumulation in experimental glomerulonephritis.

Item
http://www.wikidata.org/entity/Q33348441
Therapeutic targeting of redox signaling in myofibroblast differentiation and age-related fibrotic diseaseActivated CD47 regulates multiple vascular and stress responses: implications for acute kidney injury and its managementMesangial pathology in glomerular disease: targets for therapeutic intervention.Endothelial nitric oxide synthase controls the expression of the angiogenesis inhibitor thrombospondin 2Tadalafil Integrates Nitric Oxide-Hydrogen Sulfide Signaling to Inhibit High Glucose-induced Matrix Protein Synthesis in PodocytesRedox signaling as a therapeutic target to inhibit myofibroblast activation in degenerative fibrotic diseasePhosphodiesterase type 5 inhibitors and kidney disease.Regulation of cellular redox signaling by matricellular proteins in vascular biology, immunology, and cancerThe role of cGMP and its signaling pathways in kidney disease.Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in non-insulin-dependent Otsuka Long-Evans Tokushima Fatty rats.Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.Differences in the renal antifibrotic cGMP/cGKI-dependent signaling of serelaxin, zaprinast, and their combination.
P2860

PDE-5 inhibition impedes TSP-1 expression, TGF-beta activation and matrix accumulation in experimental glomerulonephritis.

Item
http://www.wikidata.org/entity/Q33348441
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
PDE-5 inhibition impedes TSP-1 ...... perimental glomerulonephritis.
@ast
PDE-5 inhibition impedes TSP-1 ...... perimental glomerulonephritis.
@en
type
label
PDE-5 inhibition impedes TSP-1 ...... perimental glomerulonephritis.
@ast
PDE-5 inhibition impedes TSP-1 ...... perimental glomerulonephritis.
@en
prefLabel
PDE-5 inhibition impedes TSP-1 ...... perimental glomerulonephritis.
@ast
PDE-5 inhibition impedes TSP-1 ...... perimental glomerulonephritis.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
PDE-5 inhibition impedes TSP-1 ...... perimental glomerulonephritis.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921